6505--Ga68 PSMA Injection (Illucix)
ID: 36C25724Q0988Type: Combined Synopsis/Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF257-NETWORK CONTRACT OFFICE 17 (36C257)ARLINGTON, TX, 76006, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/bdb5d68126f44a32bfe9dbe1d5eb9b2c/view
Timeline
    Description

    The Department of Veterans Affairs is seeking a contractor to provide Gallium Ga68 (Ga68-PSMA; Illucix®) radiopharmaceutical injections for the VA North Texas Health Care System, with a focus on PET imaging of prostate cancer lesions. The procurement requires contractors to possess a valid license from the US Nuclear Regulatory Commission and adhere to federal and state regulations regarding the handling and transportation of radioactive materials, ensuring safe and efficient delivery of essential medical supplies. Interested parties must submit their quotations by October 8, 2024, at 3:00 PM CST, to the designated Contract Specialist, Vance Farrell, via email, with the anticipated delivery period set from October 25, 2024, to October 24, 2025.

    Point(s) of Contact
    Vance FarrellContract Specialist
    (210) 694-6379
    vance.farrell@va.gov
    Files
    Title
    Posted
    _rels/.rels
    [Content_Types].xml
    52.225-6 - Trade Agreements Certificate.docx
    The document outlines the Trade Agreements Certificate, which is a provision that requires offerors to certify that their products are either U.S.-made or from designated countries, as specified in the solicitation. Any products that do not meet these criteria must be listed separately, along with their country of origin. The government evaluates offers based on the Federal Acquisition Regulation (FAR) policies, allowing for U.S.-made or designated country products to be considered without being subject to the Buy American statute for items covered by the WTO GPA. Offers of non-qualifying products will only be considered if there are no available offers for compliant products or if the compliant offers do not adequately meet the solicitation requirements. This provision emphasizes compliance with trade agreements and the importance of sourcing U.S.-made or designated country products in federal procurement.
    A1 - Statement of Work - Ga68 PSMA.pdf
    The VA North Texas Health Care System (VANTHCS) seeks a contractor for the manufacturing and delivery of Gallium Ga68 (Ga68-PSMA; Illucix®) radiopharmaceutical injections intended for PET imaging of prostate cancer lesions. Contractors must possess a valid license from the US Nuclear Regulatory Commission and comply with various federal and state regulations regarding the handling and transportation of radioactive materials. The contract stipulates the provision of unit doses or bulk deliveries, adequate quality control, and the need for contingency planning to ensure continuous patient care. Deliverables include thorough labeling of doses, adherence to safety standards, and the submission of Material Safety Data Sheets (MSDS). Additionally, pricing will be based on unit doses without surcharges, and the contractor must accept returns under specified conditions. All orders are to be placed by authorized VA personnel with delivery scheduled during normal business hours. The contractor will also need to provide ongoing training for VANTHCS staff regarding safety and handling practices. Overall, the document outlines a detailed framework to ensure safe, efficient delivery of essential radiopharmaceuticals for prostate cancer imaging.
    docProps/app.xml
    docProps/core.xml
    S02 - 36C25724Q0988 - SF1449.pdf
    The document outlines a government solicitation for the Department of Veterans Affairs to procure [68Ga]Ga-PSMA-11, as detailed in the Statement of Work attached. The requisition number is 36C25724Q0988, with an estimated order quantity of 50 units, required between October 25, 2024, and October 24, 2025. This solicitation is open for all businesses, particularly encouraging small business participation. Quotations are due by October 8, 2024, at 3:00 PM CDT and should be submitted electronically to the designated contracting officer, Vance Farrell, as outlined in the instructions. The document includes various sections detailing contract clauses, administrative information, delivery timelines, and the pricing structure intended for evaluation by the government. Compliance with referenced regulations and standards, including clauses for electronic payment submission, safety, and workforce requirements, is mandated. The evaluation of offers will consider both technical capabilities and pricing, emphasizing the need for a well-documented response to ensure alignment with the government's objectives. Ultimately, this solicitation seeks to facilitate the delivery of critical medical supplies to enhance VA healthcare services, reflecting the government's commitment to quality care for veterans.
    word/_rels/document.xml.rels
    word/document.xml
    word/fontTable.xml
    word/footer1.xml
    word/footer2.xml
    word/header1.xml
    word/header2.xml
    word/numbering.xml
    word/settings.xml
    word/styles.xml
    word/theme/theme1.xml
    word/webSettings.xml
    Lifecycle
    Title
    Type
    6505--Ga68 PSMA Injection (Illucix)
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Q522--PHARMACUTICAL, STL 657-24-3-1642-0121, (VA-25-00001168)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking responses to a Sources Sought Notice for a contract involving the provision of a proprietary radiopharmaceutical agent, Pluvicto, for the St. Louis VA Medical Center. This contract will cover a base year plus four option years for the supply of Lutetium LU 177 Vipivvotide Tetraxetan, which is critical for treating adult patients with prostate-specific membrane antigen (PSMA) positive metastatic castration-resistant prostate cancer. The selected contractor will be responsible for administering this radioactive diagnostic therapy via IV, with all contract administration functions retained by the Department of Veterans Affairs. Interested parties must submit their responses by September 20, 2024, at 3:00 PM CST, to Michael P. Murphy at michael.murphy7@va.gov, including their Unique Entity ID and relevant qualifications.
    6505--Radiopharmaceuticals for nuclear medicine VA patients
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for an Indefinite Delivery Indefinite Quantity (IDIQ) contract to supply radiopharmaceuticals for nuclear medicine patients at the Boise VA Medical Center. The procurement aims to ensure the availability of various nuclear medicine supplies over a five-year period, starting November 1, 2024, with requirements for 24/7 availability and emergency deliveries within 90 minutes for urgent orders. This initiative is crucial for providing high-quality medical treatment to VA patients, emphasizing compliance with federal regulations and timely service delivery. Interested parties must submit their proposals by October 3, 2024, at 1:00 PM Pacific Time, and can direct inquiries to Jose E Ronstadt at jose.ronstadt@va.gov or by phone at 360-852-9885.
    6505--Supply, Axumin-Axumin + Cerianna Medicines - Nuclear Med, CLE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to solicit and negotiate exclusively with PetNet Solutions and TrillaMed for the supply of three proprietary radiopharmaceuticals—Axumin, Amyvid, and Cerianna—for the Nuclear Medicine Service at the Louis Stokes Cleveland VA Medical Center. These products are critical for diagnosing recurrent prostate cancer, breast cancer, and Alzheimer’s disease, necessitating the use of a local radiopharmacy due to their radioactive nature and short shelf life. Interested vendors may submit their capabilities until September 18, 2024, to determine if a competitive procurement process is feasible, with all inquiries directed to Contract Specialist Don Caldwell at don.caldwell@va.gov.
    6505--Notice of Intent to Sole Source Pluvicto and Lutathera
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole source contract to Advanced Accelerator Applications USA for the provision of Pluvicto and Lutathera, specialized radiopharmaceuticals used in the treatment of metastatic castration-resistant prostate cancer and gastroenteropancreatic neuroendocrine tumors. This procurement is justified under FAR regulations due to the unique and highly specialized nature of the therapies required, which limits the availability of suitable suppliers. Interested parties are invited to submit their capability statements, including qualifications and relevant contract information, by 10:00 AM PT on September 25, 2024, to Peter Kim at peter.kim33@va.gov. The contracting office is located in Long Beach, CA, and responses must be submitted electronically; failure to respond may result in the contract being awarded without further solicitation.
    6505--Lymphoseek IDIQ
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 22, intends to award a Sole Source contract for the procurement of Lymphoseek, a proprietary radiopharmaceutical, primarily for use at the VA Loma Linda Healthcare System. This contract, designated as Solicitation Number 36C26225Q0026, will be structured as a Firm Fixed-Price Indefinite Quantity Indefinite Delivery (IDIQ) with a base year and four option years, with an estimated quantity of 86 study doses required annually. Lymphoseek is critical for identifying sentinel lymph nodes in melanoma patients, providing superior image quality due to its targeted action on the CD206 receptor. Interested parties may submit a capabilities statement by September 27, 2024, at 10:00 AM Pacific Time, and should direct inquiries to Hestia Sim at Hestia.Sim@va.gov.
    Q527--Intent to Sole Source Radiopharm Isotopes-Wilkes-Barre VAMC
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through Network Contracting Office 4, intends to issue a sole source contract for the provision of Radiopharmaceutical Isotopes to the Wilkes-Barre VA Medical Center, specifically with Jubilant Draximage Radiopharmaceuticals Inc. The contract aims to ensure the timely delivery of radiopharmaceuticals that comply with U.S. Nuclear Regulatory Commission (NRC) and Food and Drug Administration (FDA) regulations, thereby prioritizing patient safety and effective healthcare for veterans. This procurement is critical for maintaining high-quality medical services, as the contractor will be required to adhere to strict quality control measures, provide emergency services, and ensure proper packaging and labeling of all materials supplied. Interested vendors must submit a capability statement by September 20, 2024, to the Contracting Specialist, Christa Stine, at christa.stine@va.gov.
    Q517--Hazardous Compounding
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for hazardous compounding services to support the Gulf Coast Veterans Health Care System, specifically for providing compounded hazardous chemotherapy agents at its facilities in Biloxi, MS, and Pensacola, FL. The contract will be structured as a firm-fixed price, indefinite-delivery, indefinite-quantity agreement, with a base period from October 1, 2024, to September 30, 2025, and the option for four additional one-year extensions. This procurement is critical for ensuring the timely and compliant delivery of essential medical treatments to veterans, adhering to FDA and USP standards while emphasizing quality assurance and regulatory compliance. Interested contractors should submit their proposals and past performance questionnaires by 12 PM CT on September 20, 2024, and can direct inquiries to Contracting Officer Tina L. Harris at Tina.Harris3@va.gov.
    H266--Fayetteville Personnel Dosimetry Service
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking potential vendors to provide Personnel Dosimetry Services for the Fayetteville VA Healthcare System located in Fayetteville, NC. The procurement aims to establish a radiation dosimetry program compliant with the Nuclear Regulatory Commission (NRC) and the Occupational Health and Safety Administration (OSHA), which is essential for monitoring personnel working with x-rays or radioactive materials. This opportunity is particularly significant as it prioritizes Service-Disabled Veteran-Owned Small Businesses (SDVOSB) and Veteran-Owned Small Businesses (VOSB) in the bidding process, with a contract period anticipated to include a base year and four additional option years. Interested vendors must submit their capability statements and relevant information to Contract Specialist Jonathan Lamb via email by September 20, 2024, at 12:00 PM EST.
    QA software and equipment for radiotherapy beam dosimetry systems
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified contractors to provide Quality Assurance (QA) software and equipment for radiotherapy beam dosimetry systems, specifically authorized distributors of Sun Nuclear equipment. The procurement includes three specific packages: the Sun Nuclear Dosimetry Package, Patient Quality Management Package, and Machine Quality Management Package, all of which are essential for ensuring quality management in radiotherapy. This Sources Sought Notice aims to identify potential contractors and is part of the VA's Veterans First Contracting Program, which prioritizes contracts for Service-Disabled Veteran-Owned Small Businesses (SDVOSBs) and Veteran-Owned Small Businesses (VOSBs). Interested parties must respond by September 16, 2024, and can contact Robert Bleichner at robert.bleichner@va.gov for further information.
    Teleradiology Services for VASNHCS
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for Teleradiology Services for the Veterans Affairs Southern Nevada Health Care System (VASNHCS). The contract requires certified or board-eligible radiology physicians to provide remote diagnostic imaging services, including CT, MRI, and ultrasound scans, in accordance with strict American College of Radiology standards. This procurement is critical for ensuring timely and accurate diagnostic services for veterans, with an estimated total contract value of $19 million over the performance period from December 1, 2024, to November 30, 2029. Interested vendors should contact Maricela A Berrones-Gauger at maricela.berrones-gauger@va.gov for further details and to submit proposals, adhering to the Service-Disabled Veteran-Owned Small Business (SDVOSB) set-aside requirements.